Pacific Biosciences Of California ROA 2009-2019 | PACB

Current and historical return on assets (ROA) values for Pacific Biosciences Of California (PACB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Pacific Biosciences Of California ROA for the three months ending June 30, 2019 was -62.46%.
Pacific Biosciences Of California ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $-0.11B $0.17B -62.54%
2019-03-31 $-0.11B $0.19B -64.50%
2018-12-31 $-0.10B $0.17B -63.68%
2018-09-30 $-0.09B $0.18B -59.90%
2018-06-30 $-0.09B $0.14B -60.40%
2018-03-31 $-0.09B $0.16B -58.40%
2017-12-31 $-0.09B $0.14B -60.39%
2017-09-30 $-0.09B $0.16B -59.67%
2017-06-30 $-0.09B $0.18B -57.05%
2017-03-31 $-0.08B $0.14B -53.24%
2016-12-31 $-0.07B $0.14B -49.49%
2016-09-30 $-0.06B $0.15B -37.74%
2016-06-30 $-0.04B $0.16B -27.07%
2016-03-31 $-0.03B $0.14B -25.64%
2015-12-31 $-0.03B $0.13B -28.57%
2015-09-30 $-0.05B $0.10B -45.90%
2015-06-30 $-0.06B $0.10B -53.45%
2015-03-31 $-0.07B $0.11B -55.83%
2014-12-31 $-0.07B $0.12B -51.26%
2014-09-30 $-0.06B $0.12B -48.58%
2014-06-30 $-0.08B $0.13B -53.76%
2014-03-31 $-0.08B $0.14B -53.90%
2013-12-31 $-0.08B $0.14B -55.42%
2013-09-30 $-0.08B $0.15B -59.61%
2013-06-30 $-0.09B $0.13B -62.32%
2013-03-31 $-0.09B $0.14B -59.86%
2012-12-31 $-0.10B $0.13B -59.10%
2012-09-30 $-0.10B $0.15B -52.53%
2012-06-30 $-0.10B $0.17B -49.70%
2012-03-31 $-0.10B $0.20B -44.74%
2011-12-31 $-0.11B $0.22B -43.78%
2011-09-30 $-0.12B $0.24B -45.02%
2011-06-30 $-0.13B $0.26B -54.92%
2011-03-31 $-0.15B $0.28B -81.12%
2010-12-31 $-0.14B $0.31B -128.44%
2010-06-30 $-0.09B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.857B $0.079B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $109.454B 23.32
Intuitive Surgical (ISRG) United States $57.612B 50.39
Edwards Lifesciences (EW) United States $44.757B 43.56
IDEXX Laboratories (IDXX) United States $23.509B 58.98
Fresenius Medical Care AG KGaA (FMS) Germany $19.957B 13.22
Teleflex (TFX) United States $17.035B 36.16
Olympus (OCPNY) Japan $16.189B 121.13
SONOVA HOLDING (SONVY) Switzerland $14.665B 0.00
DexCom (DXCM) United States $14.456B 214.23
Hologic (HOLX) United States $13.317B 21.02
STERIS (STE) Ireland $12.870B 29.68
Sysmex ADR (SSMXY) Japan $12.420B 33.48
Varian Medical Systems (VAR) United States $9.773B 23.38
ABIOMED (ABMD) United States $8.715B 49.89
Masimo (MASI) United States $7.964B 48.32
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.135B 22.91
Penumbra (PEN) United States $5.054B 181.56
Elekta AB (EKTAY) Sweden $4.932B 39.35
Globus Medical (GMED) United States $4.827B 30.64
LivaNova (LIVN) United Kingdom $3.751B 28.60
Cantel Medical (CMD) United States $3.706B 37.59
Tandem Diabetes Care (TNDM) United States $3.350B 0.00
Wright Medical Group (WMGI) Netherlands $2.662B 233.44
Nihon Kohden (NHNKY) Japan $2.529B 25.45
Nevro (NVRO) United States $2.495B 0.00
Integer Holdings (ITGR) United States $2.473B 17.49
Glaukos (GKOS) United States $2.210B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.724B 31.97
Silk Road Medical (SILK) United States $1.230B 0.00
Veracyte (VCYT) United States $1.205B 0.00
OPKO Health (OPK) United States $1.170B 0.00
Natus Medical (NTUS) United States $1.031B 24.02
Accelerate Diagnostics (AXDX) United States $0.977B 0.00
CryoLife (CRY) United States $0.974B 92.79
ORTHOFIX MEDICAL INC (OFIX) United States $0.952B 29.89
Inogen (INGN) United States $0.940B 23.05
Tactile Systems Technology (TCMD) United States $0.924B 114.19
Luminex (LMNX) United States $0.921B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.38
Quotient (QTNT) Switzerland $0.714B 0.00
AngioDynamics (ANGO) United States $0.699B 22.87
AxoGen (AXGN) United States $0.573B 0.00
Intersect ENT (XENT) United States $0.503B 0.00
OrthoPediatrics (KIDS) United States $0.464B 0.00
Si-Bone (SIBN) United States $0.457B 0.00
Fluidigm (FLDM) United States $0.443B 0.00
ViewRay (VRAY) United States $0.387B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.372B 14.29
GenMark Diagnostics (GNMK) United States $0.369B 0.00
Alphatec Holdings (ATEC) United States $0.343B 0.00
Sientra (SIEN) United States $0.316B 0.00
Semler Scientific (SMLR) United States $0.312B 52.75
Accuray (ARAY) United States $0.269B 0.00
IRadimed (IRMD) United States $0.239B 39.62
RTI Surgical (RTIX) United States $0.222B 33.33
SeaSpine Holdings (SPNE) United States $0.204B 0.00
Neuronetics (STIM) United States $0.178B 0.00
Stereotaxis (STXS) United States $0.167B 0.00
ConforMIS (CFMS) United States $0.126B 0.00
Sensus Healthcare (SRTS) United States $0.104B 0.00
Second Sight Medical Products (EYES) United States $0.097B 0.00
EDAP TMS S.A (EDAP) France $0.086B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Ekso Bionics Holdings (EKSO) United States $0.063B 0.00
Spectral Diagnostics (EDTXF) Canada $0.062B 0.00
Helius Medical Technologies (HSDT) United States $0.052B 0.00
Vermillion (VRML) United States $0.052B 0.00
T2 Biosystems (TTOO) United States $0.036B 0.00
Nuvectra (NVTR) United States $0.028B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.027B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Ra Medical Systems (RMED) United States $0.025B 0.00
ReWalk Robotics (RWLK) Israel $0.025B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Bioanalytical Systems (BASI) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
Lianluo Smart (LLIT) China $0.016B 0.00
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Dynatronics (DYNT) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00